Executives from Praxis Precision Medicines (NASDAQ:PRAX) used a fireside chat at the Guggenheim Emerging Outlook Biotech Summit 2026 to outline near-term regulatory plans and discuss commercial considerations for its central nervous system (CNS) pipeline, with a particular focus on essential tremor and epilepsy programs. Essential tremor: framing market size and unmet need Chief Executive Officer […]